Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ARO-JNJ3
- Development stage
- Preclinical
- Lead developer
- Arrowhead Pharmaceuticals
- Modality
- Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
- Administration
- Subcutaneous
01
Overview
ARO-JNJ3 is an investigational RNA interference (RNAi) therapeutic being developed by Arrowhead Pharmaceuticals under a collaboration agreement with Janssen Pharmaceuticals for undisclosed liver-expressed targets. Its exact molecular target, mechanism of action, and clinical indication have not been publicly disclosed. ARO-JNJ3 is an early-stage therapeutic presumed to employ RNA interference to reduce expression of specific genes in the liver, following the platform approach of other Arrowhead pipeline drugs. No clinical results or subject population data have been published for ARO-JNJ3 as of October 2025[5][7].
Beyond the preview
Go deeper on ARO-JNJ3.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ARO-JNJ3.